Company Overview
Cocoon Bioscience, established in 2022, specializes in the production of recombinant proteins, including high-performance growth factors and enzymes. Leveraging their proprietary CrisBio® platform, they utilize insect pupae as natural bioreactors, offering a scalable and cost-effective alternative to traditional fermentation methods. Their technology caters to various industries, including life sciences, pharmaceuticals, and food production, aiming to address protein production challenges and enhance accessibility to advanced therapies and sustainable food sources. :contentReference[oaicite:0]{index=0}